EMA Accepts Otarmeni Gene Therapy for OTOF-Related Hearing Loss for Review
If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.
If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.
Participants discuss the importance of enhancing the use of hearing aids with additional products that help meet patients’ communication needs in a variety of situations.
The new app provides AI-powered, always-on captions to improve accessibility for people with hearing loss.
The Rooted & Regulated Retreat will offer mind/body practices and nervous system regulation tools for hearing healthcare professionals.
The company’s OtoKiosk digital audiometer and Amplifon App were recognized by the UX Design Awards and iF Design Awards for user experience and innovation.
The cloud-based service has more than doubled its user base in the last year, attracting hearing care businesses with features like remote access and simplified data management.